EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN

Jian-Ching Wu, Chao-Cheng Huang iD, Pei-Wen Wang, Ting-Ya Chen, Wen-Ming Hsu, Jiin-Haur Chuang, Hui-Ching Chuang iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jian-Ching Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan. Hauptthemen laut MEDLINE: Intellectual Disability, alpha-Thalassemia, Neuroblastoma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma (NB) is characterized by several malignant phenotypes that are difficult to treat effectively without combination therapy. The therapeutic implication of mitochondrial ClpXP protease ClpP and ClpX has been verified in several malignancies, but is unknown in NB. Firstly, we observed a significant increase in ClpP and ClpX expression in immature and mature ganglion cells as compared to more malignant neuroblasts and less malignant Schwannian-stroma-dominant cell types in human neuroblastoma tissues. We used ONC201 targeting ClpXP to treat NB cells, and found a significant suppression of mitochondrial protease, i.e., ClpP and ClpX, expression and downregulation of mitochondrial respiratory chain subunits SDHB and NDUFS1. The latter was associated with a state of energy depletion, increased reactive oxygen species, and decreased mitochondrial membrane potential, consequently promoting apoptosis and suppressing cell growth of NB. Treatment of NB cells with ONC201 as well as the genetic attenuation of ClpP and ClpX through specific short interfering RNA (siRNA) resulted in the significant upregulation of the tumor suppressor alpha thalassemia/mental retardation X-linked (ATRX) and promotion of neurite outgrowth, implicating mitochondrial ClpXP proteases in MYCN-amplified NB cell differentiation. Furthermore, ONC201 treatment significantly decreased MYCN protein expression and suppressed tumor formation with the reactivation of ATRX expression in MYCN-amplified NB-cell-derived xenograft tumors. Taken together, ONC201 could be the potential agent to provide diversified therapeutic application in NB, particularly in NB with MYCN amplification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual Disabilityalpha-ThalassemiaNeuroblastomaHumansN-Myc Proto-Oncogene ProteinCell Line, TumorMitochondriaPeptide HydrolasesGene Expression Regulation, NeoplasticX-linked Nuclear ProteinImidazolesPyridinesPyrimidines

Stichwörter der Autor:innen

ATRXClpPX proteaseMYCNONC201apoptosismitochondrianeuroblastoma

Substanzen

N-Myc Proto-Oncogene ProteinPeptide HydrolasesX-linked Nuclear ProteinTIC10 compoundImidazolesPyridinesPyrimidinesATRX protein, humanMYCN protein, human

Autor:innen und Institutionen

  • Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
  • Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
  • Biobank and Tissue Bank, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
  • Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
  • Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10617, Taiwan.
  • Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

ORCID-Profile: Chao-Cheng Huang, Hui-Ching Chuang

Förderung

  • Chang Gung Memorial Hospital, Taiwan

Zitieren

APA

Wu, J. C., Huang, C. C., Wang, P. W., Chen, T. Y., Hsu, W. M., Chuang, J. H., & Chuang, H. C. (2023). ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021649

Vancouver

Wu JC, Huang CC, Wang PW, Chen TY, Hsu WM, Chuang JH, et al. ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021649

BibTeX
@article{Wu2023,
  author = {Wu, Jian-Ching and Huang, Chao-Cheng and Wang, Pei-Wen and Chen, Ting-Ya and Hsu, Wen-Ming and Chuang, Jiin-Haur and Chuang, Hui-Ching},
  title = {ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021649}
}
Kostenlos starten →